Αναζήτηση

Τα αποτελέσματά σας

Εμφάνιση 8 από 8 αποτελέσματα

On 5 July 2023, the Commission tabled a proposal for a regulation on certain new genomic techniques (NGTs). It establishes two categories of plants obtained by NGTs: plants comparable to naturally occurring or conventional plants, and plants with modifications that are more complex. The two categories will be subject to different requirements to reach the market, taking into account their differing characteristics and risk profiles. Feedback from stakeholders is mixed. While industry interest groups ...

Algorithm-generated diets tailored to our individual needs could bring health benefits, but at the cost of having to share our most personal data, such as our DNA. The promises are many, but so are the open questions about interactions between genes, nutrients, environment and health, and the role of socioeconomic factors underlying food choices. Precision nutrition advice, services and products will need to be governed by a range of laws and policies, as they are at the intersection between food ...

What if we sequenced all human genomes?

Εν συντομία 27-06-2022

The rapid growth of genetic databases worldwide, coupled with fast-decreasing costs and the rapid pace of technological change, has increased the possibility of every human genome on Earth being sequenced this century. This raises ethical and legal questions on data privacy and ownership. While a global genetic database would revolutionise preventive medicine and research, new forms of surveillance, discrimination and power imbalances could emerge. The global interplay between the individual, the ...

Genome editing is a powerful new tool allowing precise additions, deletions and substitutions in the genome. The development of new approaches has made editing of the genome much more precise, efficient, flexible, and less expensive, relative to previous strategies. As with other medical advances, each such application comes with its own set of benefits, risks, ethical issues and societal implications, which may require new regulatory frameworks. Important questions raised with respect to genome ...

What if consumers could use devices to sequence DNA?

Εν συντομία 11-05-2021

Sequencing and analysis of the human genome – all the genetic information stored in our DNA – provide us with understanding about a person's ancestry, health and other traits. Thanks to DNA sequencing, medicine and the life sciences are able to predict and cure diseases. As DNA sequencing technologies continuously improve and become less costly, what if we all soon possessed our personal, smart DNA sequencers and apps to analyse our DNA?

What if a simple DNA test could predict your future?

Εν συντομία 22-03-2019

What if new-born babies were given a DNA report card that predicted their intelligence, their odds of getting a PhD, their chances of becoming a chain smoker or suffering depression, a heart attack or cancer? Thanks to ongoing genetic studies, a large amount of genetic data is available today involving millions of people. The wealth of information available to researchers allows them to create a polygenic risk score based on the DNA test of a person. This can be used to predict a person's chances ...

This study, commissioned by the European Parliament’s Policy Department for Citizens’ Rights and Constitutional Affairs at the request of the LIBE Committee, provides an overview of the Prüm regime. It first considers the background of the Prüm Convention and Prüm Decision. The subsequent two chapters summarize the Prüm regime in relation mainly to DNA data looking at value and shortcomings; and ethical, legal and social implications of forensic DNA typing and databasing in relation to the Prüm regime ...

Organoids are artificially grown organs that mimic the properties of real organs. What new possibilities for treating diseases, drug development, and personalised and regenerative medicine do organoids provide?